%0 Journal Article %D 2012 %T CMV encephalitis in BMT recipients %A Sarva,H. %A Graber,J. %A Remanan,R. %A Rosenblum,M. %A Omuro,A. %K Clinical Medicine %K Life & Biomedical Sciences. %X References: 1 Reddy SM, Winston DJ, Territo MC, Schiller GJ. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 2010; 45: 979-984. 2 Miller GG, Boivin G, Dummer JS, McConnell T, Becher MW, Kassim A et al. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin Infect Dis 2006; 42: e26-e29. 3 Janowicz DM, Johnson RM, Gupta SK. Successful treatment of CMV ventriculitis immune reconstitution syndrome. J Neurol Neurosurg Psychiatry 2005; 76: 891-892. 4 Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999; 190: 177-182. 5 Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid in AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2552-2554. 6 Wolf DG, Lurrain NS, Zuckerman T, Hoffman R, Satinger J, Honigman A et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 2003; 101: 463-465. %V 47 %P 18 %8 February %G English %N 2 %M 00002605-201202000-00032 %< LETTER TO THE EDITOR %R 10.1038/bmt.2011.80